Anti Fungal Drugs Market
Description
Anti Fungal Drugs Market, By Drug Type (Echinocandins, Polyenes, Allylamines, Azoles, Others), By Indication (Aspergillosis, Dermatophytosis, Candidiasis, Mucormycosis, Others), By Dosage Form (Powders, Ointments, Injections, Tablets, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
An antifungal agent is a drug that selectively eliminates fungal pathogens from a host with minimal toxicity to the host. Antifungal medicines treat fungal infections. Fungus in the soil, air, and on the skin can cause yeast infections, ringworm, and nail and skin infections. Breathing in fungal spores can lead to respiratory illnesses. Fungal infections can affect the circulatory system, respiratory system, and the skin and nails. Antifungal medicines can kill a fungus. Or they may stop it from multiplying or growing. There are several classes of antifungal medications and different types of medicines. Common fungal infections treated with anti-fungal medication include ringworm, athlete’s foot, fungal nail infection, vaginal thrush, severe type of dandruff, and others. Antifungal drugs can work in two ways: by directly killing fungal cells or by preventing fungal cells from growing and thriving. Antifungal drugs target structures or functions that are necessary in fungal cells but not in human cells, so they can fight a fungal infection without damaging the body’s cells. Two structures that are commonly targeted are the fungal cell membrane and the fungal cell wall. Both of these structures surround and protect the fungal cell. When either one becomes compromised, the fungal cell can burst open and die.Market Dynamics
Increasing product launches by the key players in the market are expected to drive the growth of the global anti fungal drugs market over the forecast period. For instance, in April 2022, Dr. Reddy's Laboratories, a pharmaceutical company, announced the launch of the Posaconazole delayed-release tablets in the U.S. market. Posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.
Key features of the study:
- This report provides an in-depth analysis of the global anti fungal drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global anti fungal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Te key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc., Alembic Pharmaceuticals Limited, and SCYNEXIS, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global anti fungal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti fungal drugs market
- By Drug Type:
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
- By Application:
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
- By Indication:
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
- By Dosage Form :
- Powders
- Ointments
- Injections
- Tablets
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- GlaxoSmithKline Plc.
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc
Table of Contents
164 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
